Gordon L. Johnson - 20 Feb 2025 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Feb 2025, 13:47:46 UTC
Prior SEC filing
26 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gordon L. Johnson by Jonathan J. Doyle as Attorney-in-Fact

Key filing fact

Gordon L. Johnson filed Form 4 for RAYMOND JAMES FINANCIAL INC (RJF) on 24 Feb 2025.

Key facts

  • This page summarizes Gordon L. Johnson's Form 4 filing for RAYMOND JAMES FINANCIAL INC (RJF).
  • 9 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2025, 13:47.

Change

  • Previous filing in this sequence was filed on 26 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RJF transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,711
Change %
+4.2%
Price
$0.000000
Shares after
42,353
Date
20 Feb 2025
Ownership
Direct
Footnotes
F1
RJF transaction

Common Stock

Award

Transaction value
$0
Shares
+1,253
Change %
+3%
Price
$0.000000
Shares after
43,606
Date
20 Feb 2025
Ownership
Direct
Footnotes
F2, F3
RJF transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+342
Change %
+0.78%
Price
$0.000000
Shares after
43,948
Date
20 Feb 2025
Ownership
Direct
Footnotes
F1
RJF transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+342
Change %
+0.78%
Price
$0.000000
Shares after
44,290
Date
20 Feb 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RJF transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+250
Change %
+10%
Price
$0.000000
Shares after
2,645
Date
20 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250
Exercise price
Footnotes
F1, F4
RJF transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+250
Change %
+9.5%
Price
$0.000000
Shares after
2,895
Date
20 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250
Exercise price
Footnotes
F1, F4
RJF transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-342
Change %
-13%
Price
$0.000000
Shares after
2,211
Date
20 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
342
Exercise price
Footnotes
F1, F5
RJF transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-342
Change %
-12%
Price
$0.000000
Shares after
2,553
Date
20 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
342
Exercise price
Footnotes
F1, F5
RJF transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,711
Change %
-77%
Price
$0.000000
Shares after
500
Date
20 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,711
Exercise price
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.

Footnote F2

Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the fifth anniversary of the vest date.

Footnote F3

Includes DRSUs.

Footnote F4

The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2026.

Footnote F5

The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

SEC remarks

This Form 4 reports (i) the acquisition by the reporting person of DRSUs resulting from an annual grant to the registrant's non-executive directors, (ii) a grant of RSUs to non-executive directors of Raymond James Bank, a subsidiary of registrant, (iii) a grant of RSUs to non-executive directors of TriState Capital Bank, a subsidiary of registrant, and (iv) the vesting of RSUs awarded to the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .